IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria

Yosifova, A; Micheva, I; Donchev, M; Tincheva, S; Ormandjiev, S; Genova, J; Pavlova, Z; Todorova, A

doi:10.2478/bjmg-2024-0003

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One of the best established CLL prognostic markers is the somatic hypermutational status of the IGHV gene which is a part of the immunoglobulin heavy chain variable region. Technology for IGHV genotyping has been optimized and has been applied in routine diagnostics for the first time in Bulgaria. A total of 105 patients with CLL from different Bulgarian regions were tested. IGHV mutational status was determined by Sanger sequencing on total genomic DNA (gDNA) or RNA extracted from mononuclear cells. All sequencing profiles were analyzed with the IMGT/V-QUEST tool. Within the course of the analysis a high percentage of IGHV unmutated status was established in the Varna district on the Black Sea (Northeast Bulgaria). In addition, the IGHV genotyping performed on gDNA revealed a rare case with multiple rearrangements. The present data from IGHV genotyping will help in choosing the proper treatment for the benefit of Bulgarian CLL patients.

References

Rajendra ND, Tarun W, Franco F et al. Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia, Blood, Volume 94, Issue 6, 1999, Pages 1840–1847.
Search in Google Scholar Back to article
Sutton, L. A., et al. Immunoglobulin genes in chronic lymphocytic leukemia: Key to understanding the disease and improving risk stratification. Haematologica. 102 (6), 968–971 (2017).
Search in Google Scholar Back to article
Ten Hacken E, Gounari M, Ghia P et al. The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia. Leukemia. 2019 Feb;33(2):287–298. doi: 10.1038/s41375-018-0303-x. Epub 2018 Dec 16. PMID: 30555163; PMCID: PMC7182338.
Open DOI Search in Google Scholar Back to article
Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S41–52. doi: 10.1016/j.jaci.2009.09.046. PMID: 20176268; PMCID: PMC3670108
Open DOI Search in Google Scholar Back to article
Calis JJ, Rosenberg BR. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol. 2014;35(12):581–590.
Search in Google Scholar Back to article
Agathangelidis A, Chatzidimitriou A, Chatzikonstantinou T et al. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL. Leukemia 2022; 36, 1961–1968.
Search in Google Scholar Back to article
Huet, Sarah & Bouvard, Anne & Ferrant, Emmanuelle & Mosnier, Isabelle & Chabane, Kaddour & Salles, Gilles & Michallet, Anne-Sophie & Hayette, Sandrine & Sujobert, Pierre. (2020). Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia. Leukemia. 34. 10.1038/s41375-020-0716-1.
Open DOI Search in Google Scholar Back to article
Agathangelidis A, Sutton LA, Hadzidimitriou A et al. Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation. 2018 J. Vis. Exp. (141)
Search in Google Scholar Back to article
Matthews C, Catherwood M, Morris TC et al. Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma. 2004 Sep;45(9):1899–904.
Search in Google Scholar Back to article
Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503–8.
Search in Google Scholar Back to article
Jain P, Nogueras Gonzalez GM, Kanagal-Shamanna R. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. Br J Haematol. 2018; 180(1):33–40.
Search in Google Scholar Back to article
Darzentas N. ARResT/Interrogate Immunoprofiling Platform: Concepts, Workflows, and Insights. 2022 May 28. In: Langerak AW, editor. Immunogenetics: Methods and Protocols [Internet]. New York: Humana; 2022. Chapter 26. Available from: https://www.ncbi.nlm.nih.gov/books/NBK586953/ doi: 10.1007/978-1-0716-2115-8_26;
Open DOI Search in Google Scholar Back to article
Bystry V, Agathangelidis A, Bikos V et al, also on behalf of ERIC, the European Research Initiative on CLL, ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy, Bioinformatics, Volume 31, Issue 23, December 2015, Pages 3844–3846,
Search in Google Scholar Back to article
Gaidano G, Rossi D. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):329–337. doi: 10.1182/asheducation-2017.1.329. PMID: 29222275; PMCID: PMC6142556.
Open DOI Search in Google Scholar Back to article
Hanson C. GHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL). Available from: https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll
Search in Google Scholar Back to article
Plevova K, Francova HS, Burckova K et al. Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones. Haematologica. 2014 Feb;99(2):329–38.
Search in Google Scholar Back to article
Rotbain EC, Frederiksen H, Hjalgrim H, et al. IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study. Haematologica. 2020 Jun;105(6):1621–1629
Search in Google Scholar Back to article
Gemenetzi K, Agathangelidis A, Zaragoza-Infante L et al. B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making; Frontiers in Oncology 10, 2020;
Search in Google Scholar Back to article

IGHV Mutational Status in a Cohort of Bulgarian CLL Patients: High Unmutated CLL Prevalence in North-East Bulgaria

Abstract

Paradigm

My account